ReviewDrug design, development and therapy2022

The Role of Glucagon-Like Peptide-1 Receptor Agonists (GLP-1 RA) in Diabetes-Related Neurodegenerative Diseases.

Dihe Cheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.